Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Di Poala Sr., J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Thyroxine or Iodine Therapy for Thyroid Nodules

right arrow Joseph Di Poala Sr.

1 August 1995 | Volume 123 Issue 3 | Pages 235-236


TO THE EDITOR:

I read with interest the article by La Rosa and colleagues [1], which described the treatment of benign solitary solid cold nodules of the thyroid. I question the authors' rationale for treatment. Presuming that these nodules are completely asymptomatic and truly benign, this management strategy is preventive rather than therapeutic. According to the U.S. Preventive Task Force recommendations, performance of a preventive service is based on the quality of evidence that this service results in more good than harm [2].

After the thyroid nodule is determined to be benign by fine-needle aspiration—which has been proved to be safe, accurate, and cost-effective [3]—three possibilities exist for the future course of this nodule:

1. It can remain benign at the same, smaller, or larger size. (Untreated thyroid nodules disappear in 38% of cases, and only 13% of nodules increase in size [4].)

2. New satellite benign nodules can form.

3. Cancer can develop within the nodule or outside the nodule in another part of the thyroid gland.

Because no scientific evidence in La Rosa and colleagues' study or in other studies suggests that thyroid replacement prevents malignancy or improves health or longevity, we must turn to its potential harmful effects. Thyroid replacement dosage, if not carefully adjusted, can lead to osteoporosis or thyrotoxic heart disease. Additional harm includes the cost of the medication, follow-up laboratory testing, and the inconvenience to the patient resulting from lifelong medication use.

Mayo Clinic proceedings conclude that the role of levothyroxine therapy remains uncertain and is not recommended [5]. I therefore conclude that, until further data accumulate, thyroid replacement is unjustified in the treatment of benign thyroid nodules.


References
space
up arrowTop
dotReferences

1. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solitary cold nodules of the thyroid. Ann Intern Med. 1995; 122:1-8.[Abstract/Free Full Text]

2. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Report of the U.S. Preventive Services Task Force. Baltimore: Williams & Wilkins; 1989.

3. Gharib H, Goellner R. Fine needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993; 118:282-9.

4. Kuma K, Matsuzuka F, Kobayaski A, Hirai K, Morita S, Miyauchi A, et al. Outcome of long standing solitary thyroid nodules. World J Surg. 16:583-7.

5. Gharib H. Fine needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc. 1994; 69:44-9.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Di Poala Sr., J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online